A cost-benefit analysis of genetic screening test for breast cancer in Iran
This study aimed to evaluate the implementation of the population- and family history (FH) -based screening for BReast CAncer (BRCA) in Iran, a country where less than 10% of breast cancer cases are attributab...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Zahra Meshkani, Najmeh Moradi, Ali Aboutorabi, Hiro Farabi and Nazi Moini Tags: Research Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Genetics | Iran Health | Middle East Health | Study